Letter to the editor on 'Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial' by Udwadia et al
Autor: | Mahender Kumar Medisetty, Atul Patel, Sanjay Pujari |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | International Journal of Infectious Diseases, Vol 105, Iss , Pp 722- (2021) |
Druh dokumentu: | article |
ISSN: | 1201-9712 |
DOI: | 10.1016/j.ijid.2021.02.035 |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |